3
Shared Docs
3
Same-Page
3 / 3
Mentions
efault in respect of such party or any other event which permits either party to terminate any transaction under this or any other agreement. If the European Commission adopts an implementing act in respect of the United States of America pursuant to Article 13 of EMIR and makes the declarations stated in Article
rty status, portfolio reconciliation and dispute resolution requirements set out in Regulation (EU) No 648/2012 of the European Parliament and of the Council on OTC derivatives, central counterparties and trade depositories dated 4 July 2012 ("EMIR"). Capitalized terms not otherwise defined herein have the meanings ascrib
default in respect of such party or any other event which permits either party to terminate any transaction under this or any otW agreement. If the European Commission adopts an implementing act in respect of the EFTA01467798 United States of America pursuant to Article 13 of EMIR and makes the declarations stat
rty status, portfolio reconciliation and dispute resolution requirements set out in Regulation (EU) No 648/2012 of the European Parliament and of the Council on OTC derivatives, central counterparties and trade depositories dated 4 July 2012 ("EMIR"). Capitalized terms not otherwise defined herein have the meanings ascrib
efault in respect of such party or any other event which permits either party to terminate any transaction under this or any other agreement. If the European Commission adopts an implementing act in respect of the EFTA01467842 United States of America pursuant to Article 13 of EMIR and makes the declarations stat
rty status, portfolio reconciliation and dispute resolution requirements set out in Regulation (EU) No 648/2012 of the European Parliament and of the Council on OTC derivatives, central counterparties and trade depositories dated 4 July 2012 ("EMIR"). Capitalized terms not otherwise defined herein have the meanings ascrib
Entities connected to both the European Commission and the Council on OTC derivatives